Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

67359 Press Releases
DateTitleCompany
12 Dec 11 BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies BioTime Inc.,
Published by
Business Wire
12 Dec 11 CytRx Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at ASH Conference CytRx Corporation,
Published by
Business Wire
12 Dec 11 First FDA-Approved Treatment for Myelofibrosis, Jakafi™ (ruxolitinib), Discussed in Multiple Presentations at 2011 ASH Annual Meeting Incyte Corporation,
Published by
Business Wire
12 Dec 11 Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer Geron Corporation,
Published by
Business Wire
12 Dec 11 Medidata Solutions Broadens CRO Partner Accreditations to Field Increasing Product Demand Medidata Solutions,
Published by
Business Wire
12 Dec 11 Synageva BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012 Synageva BioPharma,
Published by
Business Wire
12 Dec 11 Merganser Biotech Announces Signing of Option to License Minihepcidin Technology from UCLA Merganser Biotech Inc.,
Published by
Business Wire
12 Dec 11 Following a Near-Term Market Decline, the Launch of New Acute Therapies and Increasing Uptake of Allergan’s Botox Will Drive the Migraine Drug Market to Increase to $4.4 Billion in 2020 Decision Resources,
Published by
Business Wire
12 Dec 11 Emergent BioSolutions to Participate in January 2012 Investor Conferences Emergent BioSolutions Inc.,
Published by
Business Wire
12 Dec 11 Through 2020, Generic Erosion of Blockbuster Agents Will Be a Major Contributor to a Nearly $6 Billion Decrease in the Dyslipidemia Drug Market Decision Resources,
Published by
Business Wire
12 Dec 11 Truveris Expands Leadership Team with Additions to the Board Truveris,
Published by
Business Wire
12 Dec 11 The Combined Markets for Drugs Used in the Treatment and Prophylaxis of Venous Thromboembolism Will Increase from $3.4 Billion in 2010 to $4.7 Billion in 2020 Decision Resources,
Published by
Business Wire
12 Dec 11 U.S. Patients Are Extremely Happy with Their Doctors, New Study Shows DrScore.com,
Published by
Business Wire
12 Dec 11 Celldex Therapeutics Presents Novel Preclinical Data on CDX-1127 at the American Society of Hematology Meeting in San Diego Celldex Therapeutics Inc.,
Published by
Business Wire
12 Dec 11 ICON Acquires BeijingWits Medical Consulting Ltd ICON plc,
Published by
Business Wire
12 Dec 11 InVivo Therapeutics Co-Founder Dr. Robert S. Langer Awarded Annual Innovation Award from The Economist InVivo Therapeutics Holdings Corp.,
Published by
Business Wire
12 Dec 11 RBCC Signs Letter of Intent With Cutting-Edge Biosciences Firm Rainbow Coral Corp.,
Published by
Business Wire
12 Dec 11 BioInvent - Anti-Cancer Activity of BI-505 Demonstrated in Animal Model BioInvent International AB,
Published by
Business Wire
12 Dec 11 Results from a Comparative Analysis Shows REVLIMID® Demonstrates Statistically Significant Reduction in Risk of Death and No Evidence of Increased Risk of Progression to AML in Patients with Deletion 5q MDS Compared with Best Supportive Care Celgene International Sàrl,
Published by
Business Wire
12 Dec 11 Dosing Study Evaluates REVLIMID® in Previously Treated Patients with Chronic Lymphocytic Leukemia Celgene International Sàrl,
Published by
Business Wire
12 Dec 11 University College Dublin and Elan Announce Initiative to Create Leadership in Biotechnology Elan Corporation plc,
Published by
Business Wire
12 Dec 11 ARIAD Announces Preliminary Data from Pivotal Pace Trial of Ponatinib, Its Investigational pan-BCR-ABL Inhibitor ARIAD Pharmaceuticals Inc.,
Published by
Business Wire
12 Dec 11 ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes Array BioPharma Inc.,
Published by
Business Wire
12 Dec 11 ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple Myeloma Array BioPharma Inc.,
Published by
Business Wire
11 Dec 11 Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients Micromet Inc.,
Published by
Business Wire
11 Dec 11 Phase I Study Evaluating Oral Azacitidine as Potential Treatment for Patients With Acute Myeloid Leukemia Presented at the American Society of Hematology Meeting Celgene International Sàrl,
Published by
Business Wire
10 Dec 11 Onconova to Present Data Demonstrating Survival Benefit in MDS Patients Treated with Rigosertib and Phase I Data for Oral Rigosertib at the American Society of Hematology Annual Meeting Onconova Therapeutics,
Published by
Business Wire
10 Dec 11 Spectrum Pharmaceuticals Affirms Strong Patent Protection for FUSILEV® (levoleucovorin) Through December 31, 2019 Spectrum Pharmaceuticals Inc.,
Published by
Business Wire
10 Dec 11 Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives Abiomed Inc.,
Published by
Business Wire
10 Dec 11 Exact Sciences Announces Successful Completion of Public Offering of Common Stock Exact Sciences Corp.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.